Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences

View all Images (5)

Alpha-1 antitrypsin deficiency in Adult
Print Captions
Other Resources UpToDate PubMed

Alpha-1 antitrypsin deficiency in Adult

Print Images (5)
Contributors: Holly Berg, Jennifer J. Findeis-Hosey MD
Other Resources UpToDate PubMed

Alerts and Notices

Synopsis

Alpha-1 antitrypsin deficiency (Pulmonary Disease) : Cough, Dyspnea, Wheezing
Pulmonary Disease
Alpha-1 antitrypsin deficiency (AATD) is a congenital disorder that primarily affects the lungs and liver. It is characterized by low levels of the protein alpha-1 antitrypsin (AAT) in the blood. The deficiency is caused by mutations on the SERPINA1 gene and is inherited by autosomal co-dominant transmission. Over 150 mutations in the SERPINA1 gene have been identified and are associated with variable presentations of disease. Many of these mutations cause so-called "toxic loss of function" resulting in lack of destruction of elastase and other proteases, while others cause "toxic gain of function" leading to intracellular accumulation of abnormally polymerized AAT. The normal phenotype is PiMM; common abnormal phenotypes include PiZZ and PiMZ.

Prevalence varies considerably globally; however, it is estimated that approximately 3 million people worldwide are genotypically severely AAT deficient, and nearly 100 000 of those individuals are in the United States.

Symptoms and complications vary. Patients may have increased risk for chronic kidney disease, diabetes, metabolic alterations, ANCA-associated vasculitis, gallstone disease, emphysema, chronic obstructive pulmonary disease (COPD) (especially current and former smokers), cystic fibrosis–associated liver disease with portal hypertension, nonalcoholic fatty liver disease cirrhosis, and advanced liver fibrosis.

Patients presenting within the first four decades of life are more commonly at risk of suffering complications due to liver dysfunction. Cigarette smoking is one of the strongest drivers of rate of decline in lung function and consequently increases risk of death due to respiratory failure. Studies show that as many as 40% of AATD patients with mutations causing "toxic gain of function" accumulation of AAT in hepatocytes demonstrate histologically significant liver injury and cirrhosis at time of death. Male sex and obesity may convey an increased risk of progression of liver injury to progressive hepatic failure over other traditional liver risk factors, such as alcohol use disorder and viral hepatitis. Respiratory failure and liver disease are major causes of mortality in severely deficient patients (72% and 10%, respectively).

Codes

ICD10CM:
E88.01 – Alpha-1 Antitrypsin Deficiency

SNOMEDCT:
30188007 – Alpha-1 Antitrypsin Deficiency

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:12/12/2017
Last Updated:01/11/2022
Copyright © 2023 VisualDx®. All rights reserved.
Alpha-1 antitrypsin deficiency in Adult
Captions Print   View all Images (5)
(with subscription)
A medical illustration showing key findings of Alpha-1 antitrypsin deficiency (Pulmonary Disease) : Cough, Dyspnea, Wheezing
Clinical image of Alpha-1 antitrypsin deficiency - imageId=7397923. Click to open in gallery. caption: 'Panniculitis'
Panniculitis

+3 More images of Alpha-1 antitrypsin deficiency with subscription

Copyright © 2023 VisualDx®. All rights reserved.